Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Comprehensive Income [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 82 $ 14,486,492 $ (13,878,553) $ (42,832) $ 565,189
Beginning balance, shares at Dec. 31, 2020 817,450        
Issuance of common related to restricted stock award 14,200 14,200
Issuance of common related to restricted stock award, shares 1,000        
Comprehensive gain 1,611 1,611
Net loss (803,142) (803,142)
Issuance common stock from convertible debt $ 42 458,049 458,091
Issuance common stock from convertible debt, shares 418,437        
Beneficial conversion feature of convertible debt 340,420 340,420
Ending balance, value at Mar. 31, 2021 $ 124 15,299,161 (14,681,695) (41,221) 576,369
Ending balance, shares at Mar. 31, 2021 1,236,887        
Beginning balance, value at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 17,530,819
Beginning balance, shares at Dec. 31, 2021 7,053,146        
Issuance of common related to offering $ 223 7,004,815   7,005,038
Issuance of common related to offering, shares 2,229,950        
Issuance of common related to restricted stock award $ 1 34,799   34,800
Issuance of common related to restricted stock award, shares 10,000        
Comprehensive gain   (15,330) (15,330)
Net loss (850,083) (850,083)
Ending balance, value at Mar. 31, 2022 $ 929 $ 46,552,707 $ (22,836,298) $ (12,094) $ 23,705,244
Ending balance, shares at Mar. 31, 2022 9,293,096